|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Gain on lease termination | |||||
| Non-cash lease expense | |||||
| Amortization of operating lease right-of-use asset | |||||
| Amortization of operating lease asset | |||||
| Accretion of investment discounts | |||||
| Goodwill impairment | |||||
| Stock-based compensation | |||||
| Change in fair value of warrant liabilities | |||||
| Deferred tax provision | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of available-for-sale short-term investments | |||||
| Proceeds from maturities of available-for-sale short-term investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuances of common stock and pre-funded warrants, net | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Non-cash activities: | |||||
| Common stock exchanged for X and X1 non-voting convertible preferred stock | |||||
| Unrealized gain on available-for-sale securities | |||||
| Unrealized gain (loss) on available-for-sale securities | |||||
| Common stock exchange for warrants | |||||
| Offering costs accrued but not yet paid | |||||
| Increase in operating right-of-use lease asset and liability due to new lease | |||||
| Settlement of warrant liability into common stock due to exercise | |||||
Loading...